Navigation Links
BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
Date:4/5/2011

and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer.  The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).  BDSI's second pain product, BEMA Buprenorphine, is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation for the treatment of opioid dependence.  Additional product candidates are being developed utilizing the BEMA technology for conditions such as nausea/vomiting (BEMA Granisetron) and migraine (BEMA "Triptan").  BDSI's headquarters is located in Raleigh, North Carolina.  For more information, visit www.bdsi.com.

BDSI® and BEMA® are registered trademarks of BioDelivery Sciences International, Inc.  ONSOLIS® is a registered trademark of Meda Pharmaceuticals, Inc.  BREAKYL is registered trademark of Meda Pharma GmbH & Co. KG.

Cautionary Note on Forward-Looking Statements

This press release and the statements of representatives and partners of BioDelivery Sciences International, Inc. (the "Company") related thereto contain, or may contain, among other things, certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve significant risks and uncertainties. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, projections, expectations and intentions and other statements identified by words such as "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," or similar expressions. These statements are based upon the current beliefs and expectations of the Company's management an
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
3. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
4. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
5. TCG Lifesciences Expands Pharmaceutical, Biotechnology Research Initiatives with CAS SciFinder®
6. Sofie Biosciences Launches a High Performance, Benchtop Preclinical PET System Using New Generation Detector Technology
7. Caliper Life Sciences Launches Novel COX-2 Probe to Enable Personalized Medicine Research
8. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
9. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
10. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
11. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 A team ... atomic structure of a cell-surface receptor that plays a ... research unexpectedly discloses many new structural features, which challenge ... receptors (GPCRs) and open a new door for future ... Nature on March 30, the researchers at ...
(Date:3/30/2015)... March 30, 2015  Cochlear Corporation Vice President ... leave Cochlear to join Valencia Technologies ( www.valenciatechnologies.com ... Jeff Greiner , who is the CEO of ... Development and will be responsible for generating enthusiasm ... Valencia,s coin-sized neuromodulation device in the ...
(Date:3/30/2015)...   MultiVir Inc. ("MultiVir"), a clinical-stage gene ... for the treatment of multiple oncological indications, today announced ... Form S-1 with the U.S. Securities and Exchange Commission ... shares of its common stock. The number of shares ... proposed offering have not yet been determined. MultiVir has ...
Breaking Medicine Technology:New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2MultiVir Files Registration Statement for Proposed Initial Public Offering 2
... Reportlinker.com announces that a new market ... Levosimendan - Comprehensive patent ... Eliminate unnecessary risk with the ... Pipeline Developer is a regularly updated, ...
... /PRNewswire-Asia/--Today, patients and their families are becoming increasingly ... the comfort and familiarity of their own home. ... distributor of infrared thermometer models and ... its introduction of more advanced products. ...
Cached Medicine Technology:Levosimendan - Comprehensive Patent Search 2Levosimendan - Comprehensive Patent Search 3Levosimendan - Comprehensive Patent Search 4Enjoy Health Care Products at Home with Ease 2
(Date:3/30/2015)... TX (PRWEB) March 30, 2015 Healthy, ... to MedX Pharmacy. The staff of pharmacists is specially ... care issues like acne, eczema and other conditions. , ... with a patient’s dermatologist and/or PCP to tackle most ... pharmacy, MedX Pharmacy has employed specialty-trained pharmacists who have ...
(Date:3/30/2015)... 2015 In a recent report published ... Chris Christie is championing effective drug and alcohol treatment ... scrambling to recover funds to stabilize the addiction treatment ... victims of drug and alcohol addiction. Harbor Village Detox ... by substance use disorders in New Jersey, in hopes ...
(Date:3/30/2015)... 30, 2015 Follow us on ... to develop and establish chronic pain rehabilitation centers are ... the market is poised to benefit from the rise ... the increase in chronic health conditions such as Cancer, ... among others. While conventional treatment for pain management is ...
(Date:3/30/2015)... March 30, 2015 Recently, 10 Best ... Water Awards, with the top three winners being Fiji water, ... the company’s website, along with other informative information about water. ... water, spring water, mineral water and sparkling water are among ... of the top exotic water brands highlighted on the ...
(Date:3/30/2015)... Valerie Harper, the actress best known ... “The Mary Tyler Moore Show,” will be the keynote ... CURETM magazine announced today. Harper, who is living with ... Society’s 40th Annual Congress on April 23 in Orlando, ... nurses play in the lives of people with cancer. ...
Breaking Medicine News(10 mins):Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 2Health News:Spunky Sitcom Star and Lung Cancer Survivor Valerie Harper to Keynote Extraordinary Healer™ Award Ceremony Honoring Oncoloy Nurses 3
... Observance To Draw Attention To "The Sneak Thief of Sight" ... effort to combat one of the leading causes of blindness ... Organization have set March 12, 2009, as the second ... by awareness and educational events organized by eye care institutions ...
... neuroscience and oncology to OAPI, further strengthening the ... , ROCKVILLE, Md. and PRINCETON, N.J., Feb. ... fast-growing health care company that commercializes Otsuka-discovered and ... the appointment of Mark Altmeyer as President and ...
... (NYSE Alternext US: CUR) announced today that James ... the People,s Republic of China, has joined the ... advisor on China. (Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO )Senator ... from Tennessee in 1976 where he served for ...
... results -LAVAL, QC, Feb. 12 /PRNewswire-FirstCall/ - Labopharm Inc. ... that it will host a conference call on Thursday, ... fourth quarter 2008 financial results. Labopharm will report its ... approximately 7:00 a.m. the same day. , To access ...
... largest,integrative wellness centre of its kind in the world, ... will offer the most comprehensive,array of world-class medical treatments, ... is already a popular lifestyle and leisure,destination, can soon ... the opening,of the MaloClinicSPA in mid 2009. , ...
... Will Now Be Available to a Wider Medical Market through Nation,s ... ... 2009 -- Inviro Medical Devices, an industry leader in infection control ... of the nation,s largest and most respected GPOs, or group provider ...
Cached Medicine News:Health News:World Glaucoma Day Set For March 12, 2009 2Health News:World Glaucoma Day Set For March 12, 2009 3Health News:World Glaucoma Day Set For March 12, 2009 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 2Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 3Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 4Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 5Health News:Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer 6Health News:Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board 2Health News:Senator James Sasser, Former Ambassador to China, Joins Neuralstem Advisory Board 3Health News:Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET) 2Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 2Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 3Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 4Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 5Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 6Health News:Medical Tourism Comes to Macao -- World's Largest Integrative One-Stop Wellness Centre MaloClinicSPA Opens at The Venetian(R) Macao-Resort-Hotel 7Health News:Inviro Medical Devices Is Awarded a Three Year Contract with Leading GPO Novation 2
... Plus Chemistry Analyzer is an in vitro ... of clinical chemistry parameters using Reflotron Test Tabs. ... and ensures rapid and reliable results while being ... clear LC display and the profile can be ...
... ASR contains primers and a FAM-labeled probe targeting ... the Parvo B19 ASR contains primers and a ... This ASR requires an instrument that can detect ... System., The Cepheid Analyte Specific Reagent* (ASR) program ...
... Enterovirus ASR contains primers, a FAM-labeled probe and ... detect a 115 bp region of the 5' ... detect FAM, Alexa 532 and Texas Red reporter ... Analyte Specific Reagent* (ASR) program is comprised of ...
... The B. pertussis ASR contains primers and ... a 103 bp region of the IS481 gene. ... a Texas Red-labeled probe and DNA for an ... that can detect FAM and Texas Red reporter ...
Medicine Products: